OncoVista Innovative Therapies, Inc. filed its 10-K on Apr 15, 2015 for the period ending Dec 31, 2014. In this report its auditor, GHP Horwath, P.C, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | +9,900.00% |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 2.36T | |
+27.42% | 4.82TCr | |
-0.77% | 4.17TCr | |
+43.45% | 4.1TCr | |
-5.26% | 2.88TCr | |
+10.54% | 2.56TCr | |
-22.83% | 1.9TCr | |
+8.11% | 1.29TCr | |
+29.29% | 1.2TCr | |
-2.07% | 1.18TCr |
- Stock Market
- Equities
- OVIT Stock
- News OncoVista Innovative Therapies, Inc.
- OncoVista Innovative Therapies, Inc. Auditor Raises 'Going Concern' Doubt